Andrew A Wolff Selected Research

Ventricular Tachycardia

6/2005	Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenoson.
9/2003	Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew A Wolff Research Topics

Disease

7	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 09/2012
4	Dizziness (Lightheadedness) 01/2019 - 09/2012
4	Heart Failure 03/2016 - 08/2011
4	Ischemia 08/2014 - 01/2004
3	Disease Progression 01/2022 - 01/2018
3	Fatigue 01/2021 - 09/2012
3	Myocardial Ischemia (Ischemic Heart Diseases) 02/2005 - 01/2004
3	Stable Angina 04/2004 - 04/2002
2	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 07/2021 - 01/2021
2	Nausea 01/2021 - 01/2019
2	Systolic Heart Failure 01/2015 - 08/2011
2	Ventricular Tachycardia 06/2005 - 09/2003
1	Weight Loss (Weight Reduction) 01/2019
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2019
1	Respiratory Insufficiency (Respiratory Failure) 01/2018
1	Dyspnea (Shortness of Breath) 03/2016
1	Cardiomyopathies (Cardiomyopathy) 01/2015
1	Hypoxia (Hypoxemia) 08/2014
1	Peripheral Arterial Disease 08/2014
1	Diarrhea 03/2012
1	Breast Neoplasms (Breast Cancer) 03/2012
1	Neutropenia 03/2012
1	Anemia 03/2012
1	Left Ventricular Dysfunction 08/2011
1	Acute Coronary Syndrome 04/2007
1	Cardiac Arrhythmias (Arrythmia) 04/2007
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2005
1	Bronchial Spasm 06/2005
1	Asthma (Bronchial Asthma) 06/2005
1	Angina Pectoris 02/2005
1	Supraventricular Tachycardia 09/2003
1	Tachycardia (Tachyarrhythmias) 09/2003
1	Hypotension (Low Blood Pressure) 09/2003
1	Myocardial Infarction 04/2002

Drug/Important Bio-Agent (IBA)

6	CK-2017357IBA 01/2019 - 09/2012
5	TroponinIBA 01/2021 - 09/2012
5	Ranolazine FDA Link 04/2007 - 04/2002
4	reldesemtivIBA 01/2022 - 01/2021
4	omecamtiv mecarbilIBA 03/2016 - 08/2011
3	Cardiac MyosinsIBA 03/2016 - 08/2011
2	tecadenosonIBA 06/2005 - 09/2003
2	Atenolol (Tenormin)FDA LinkGeneric 02/2005 - 01/2004
2	Fatty Acids (Saturated Fatty Acids)IBA 04/2004 - 04/2002
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Natriuretic PeptidesIBA 03/2016
1	ispinesibIBA 03/2012
1	KinesinsIBA 03/2012
1	Proteins (Proteins, Gene)FDA Link 03/2012
1	Alanine Transaminase (SGPT)IBA 03/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2012
1	Pharmaceutical PreparationsIBA 08/2011
1	Neurofibromin 2 (Merlin)IBA 04/2007
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 06/2005
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2004
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2004
1	Diltiazem (Cardizem)FDA LinkGeneric 01/2004
1	Adenosine (Adenocard)FDA LinkGeneric 09/2003
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 09/2003
1	Glucose (Dextrose)FDA LinkGeneric 04/2002
1	Trimetazidine (Vastarel)IBA 04/2002
1	PotassiumIBA 04/2002
1	Insulin (Novolin)FDA Link 04/2002

Therapy/Procedure

1	Tracheostomy 01/2018
1	Intravenous Infusions 03/2016
1	Adjuvant Chemotherapy 03/2012
1	Therapeutics 02/2005